Target intelligence / Profile preview

Gut bacterial surface receptors and structures

Molecular classification
Peptidoglycan, Lipopolysaccharide, Surface-anchored protein, Teichoic acid, Bacterial pilus, Other
01

Overview

Gut bacterial surface receptors and structures on susceptible microbiota strains refers to the diverse array of molecular components—such as peptidoglycans, lipopolysaccharides, and surface proteins—that constitute the exterior of bacteria within the gastrointestinal tract (Lynch & Pedersen, 2016). These structures are essential for bacterial adhesion, nutrient transport, and interaction with the host immune system, serving as the primary interface between the microbiome and the human body (Belkaid & Hand, 2014). In clinical pharmacology, these components are the classical targets for antibiotics; for example, beta-lactams inhibit the synthesis of the peptidoglycan layer in susceptible strains. However, recent research has highlighted that many non-antibiotic drugs also inadvertently interact with these bacterial structures, leading to widespread dysbiosis and potential long-term health consequences (Maier et al., 2018). The selective targeting or preservation of specific microbial surface structures is a key area of research for developing precision medicines aimed at restoring gut homeostasis in diseases like inflammatory bowel disease and metabolic syndrome (Brown et al., 2013).

Other names
Gut microbial surface componentsBacterial cell wall structuresMicrobiota surface antigensCell wall-associated structures
02

Mechanism of action

Inhibition of peptidoglycan cross-linking, disruption of the bacterial outer membrane, or competitive inhibition of mucosal adhesion.

03

Biological functions

Bacterial adhesionHost-microbe signalingCell wall biosynthesisMembrane transportImmune responseOther
04

Disease associations

InflammationInfectionDysbiosisMetabolic syndromeOther
05

Safety considerations

Disruption of the commensal microbiome (dysbiosis)Increased susceptibility to opportunistic infectionsSelection for multi-drug resistant organismsJarisch-Herxheimer-like inflammatory reactions
06

Interacting drugs

Vancomycin

5 more in the full profile.

07

Biomarkers

16S rRNA gene sequencingMetagenomic diversity indicesFecal calprotectinSerum lipopolysaccharide-binding protein (LBP)

Beyond the preview

Go deeper on Gut bacterial surface receptors and structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut bacterial surface receptors and structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call